Successful control of Marek's disease by vaccination
- PMID: 15742626
Successful control of Marek's disease by vaccination
Abstract
Marek's disease (MD) is a neoplastic disease of poultry caused by the highly contagious Marek's disease virus (MDV). Vaccination with live attenuated vaccines forms the cornerstone of the current MD control programmes. The widespread use of the vaccines in the last 30 years has significantly reduced the losses from MD. Despite the huge success of the vaccination policy, the continuing trend in virulence increase of field strains of MDV has forced the introduction of new generations of vaccines to keep up with the creeping virulence increase of MDV. In these circumstances, it is very important to undertake research to develop more sustainable strategies of control. Development of new recombinant DNA technologies such as the use of bacterial artificial chromosomes (BAC) offers the possibility of developing molecularly-defined vaccines. In addition, the availability of the whole chicken genome sequence allows the opportunity of exploiting genetic resistance against MD as another sustainable strategy.
Similar articles
-
Use of Marek's disease vaccines: could they be driving the virus to increasing virulence?Expert Rev Vaccines. 2005 Feb;4(1):77-88. doi: 10.1586/14760584.4.1.77. Expert Rev Vaccines. 2005. PMID: 15757475 Review.
-
Vaccinal control of Marek's disease: current challenges, and future strategies to maximize protection.Vet Immunol Immunopathol. 2006 Jul 15;112(1-2):78-86. doi: 10.1016/j.vetimm.2006.03.014. Epub 2006 May 8. Vet Immunol Immunopathol. 2006. PMID: 16682084 Review.
-
A comparative evaluation of the protective efficacy of rMd5deltaMeq and CVI988/ Rispens against a vv+ strain of Marek's disease virus infection in a series of recombinant congenic strains of White Leghorn chickens.Avian Dis. 2011 Sep;55(3):384-90. doi: 10.1637/9524-091310-Reg.1. Avian Dis. 2011. PMID: 22017035
-
Comparative analysis of Marek's disease virus (MDV) glycoprotein-, lytic antigen pp38- and transformation antigen Meq-encoding genes: association of meq mutations with MDVs of high virulence.Vet Microbiol. 2004 Sep 8;102(3-4):147-67. doi: 10.1016/j.vetmic.2004.06.007. Vet Microbiol. 2004. PMID: 15327791
-
Construction of an infectious Marek's disease virus bacterial artificial chromosome and characterization of protection induced in chickens.J Virol Methods. 2009 Mar;156(1-2):66-72. doi: 10.1016/j.jviromet.2008.10.021. Epub 2008 Dec 16. J Virol Methods. 2009. PMID: 19026690
Cited by
-
A virulent bioluminescent and fluorescent dual-reporter Marek's disease virus unveils an alternative spreading pathway in addition to cell-to-cell contact.J Virol. 2014 Oct;88(19):11617-23. doi: 10.1128/JVI.01482-14. Epub 2014 Jul 16. J Virol. 2014. PMID: 25031355 Free PMC article.
-
Homodimerization of the Meq viral oncoprotein is necessary for induction of T-cell lymphoma by Marek's disease virus.J Virol. 2009 Nov;83(21):11142-51. doi: 10.1128/JVI.01393-09. Epub 2009 Aug 19. J Virol. 2009. PMID: 19692466 Free PMC article.
-
Emerging Hypervirulent Marek's Disease Virus Variants Significantly Overcome Protection Conferred by Commercial Vaccines.Viruses. 2023 Jun 25;15(7):1434. doi: 10.3390/v15071434. Viruses. 2023. PMID: 37515122 Free PMC article.
-
Advances in Poultry Vaccines: Leveraging Biotechnology for Improving Vaccine Development, Stability, and Delivery.Vaccines (Basel). 2024 Jan 28;12(2):134. doi: 10.3390/vaccines12020134. Vaccines (Basel). 2024. PMID: 38400118 Free PMC article. Review.
-
A Chinese Variant Marek's Disease Virus Strain with Divergence between Virulence and Vaccine Resistance.Viruses. 2017 Apr 3;9(4):71. doi: 10.3390/v9040071. Viruses. 2017. PMID: 28368367 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical